×
About 650 results

ALLMedicine™ Gastrointestinal Tumors Center

Research & Reviews  225 results

Risk factors and predictive value of perioperative neurocognitive disorders in elderly ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287702
BMC Anesthesiology; Li YL, Huang HF et. al.

Jul 21st, 2021 - This study aims to investigate the risk factors of perioperative neurocognitive disorders (PNDs) mainly including postoperative cognitive dysfunction (POCD) in elderly patients with gastrointestinal tumors, and evaluate its predictive value. A tot...

Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262654
International Journal of Molecular Medicine; Feng X, Xue F et. al.

Jul 20th, 2021 - Banxia xiexin decoction (BXXX) is a classic preparation used to treat gastrointestinal diseases, and also has certain therapeutic effects on gastrointestinal tumors. BXXX has been reported to regulate the expression of proteins associated with dru...

Specific survival nomograms based on SEER database for small intestine adenocarcinoma.
https://doi.org/10.21037/apm-21-600
Annals of Palliative Medicine; Wang D, Li C et. al.

Jul 16th, 2021 - Small intestine cancers, as an extremely rare tumor type, account only for 3% of all gastrointestinal tumors. Small intestine adenocarcinoma (SIA), representing approximately one-third of all small bowel cancers, has received relatively little att...

Population-Based Long-term Cardiac-Specific Mortality Among Patients With Major Gastroi...
https://doi.org/10.1001/jamanetworkopen.2021.12049
JAMA Network Open; Ramai D, Heaton J et. al.

Jun 18th, 2021 - Patients with major gastrointestinal (GI) cancers are at long-term risk for cardiac disease and mortality. To investigate the cardiac-specific mortality rate among individuals with major GI cancers and the association of radiation and chemotherapy...

Association between oral microflora and gastrointestinal tumors (Review).
https://doi.org/10.3892/or.2021.8111
Oncology Reports; Li X, Zhu S et. al.

Jun 17th, 2021 - The oral cavity contains the highest density and the most species of microorganisms compared with other parts of the body. Recent studies have determined that the species and abundance of oral microflora are closely associated with the development...

see more →

Guidelines  1 results

Endoscopic resection of superficial gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977951
World Journal of Gastroenterology; Marc G, Lopes CV

Aug 14th, 2008 - Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  13 results

Aprepitant Triple Therapy Caused Chemotherapy Induced Nausea And Vomiting In Gastrointestinal Tumors
https://clinicaltrials.gov/ct2/show/NCT03674294

Oct 29th, 2019 - The purpose of this study is to study whether adding Aprepitant to Palonosetron and dexamethasone can further prevent the incidence and severity of nausea and vomiting caused by FOLFIRI or FOLFOX chemotherapy regimen after curative effect among ga...

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
https://clinicaltrials.gov/ct2/show/NCT02319018

Oct 8th, 2018 - PRIMARY OBJECTIVES: I. To determine the maximum tolerated doses and the recommended phase II doses of modified fluorouracil, leucovorin calcium, oxaliplatin (mFOLFOX) given in combination with alisertib (MLN8237) in patients with gastrointestinal ...

Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
https://clinicaltrials.gov/ct2/show/NCT03507998

Apr 25th, 2018 - The purpose of the Dose Escalation Phase is to examine the safety and determine the maximum tolerated dose of CGX1321 when administered to subjects with advanced GI tumors that have relapsed or are refractory to or not considered medically suitabl...

Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
https://clinicaltrials.gov/ct2/show/NCT00954655

Aug 8th, 2017 - OBJECTIVES: Primary To examine polymorphisms in selected genes involved in the detoxifying/metabolizing and DNA repair pathways in relation to specific mutations and types of mutation in the c-kit gene in tumor tissue from patients with gastrointe...

Effect of General Anesthesia and Mechanical Ventilation on Plasma Metabolite in Patient With Colorectal Cancer Resection
https://clinicaltrials.gov/ct2/show/NCT03137628

May 3rd, 2017 - Nowadays, more and more attention are paid to system biology and its relative techniques, such as gene sequencing,nuclear magnetic resonance, mass spectrometry and so on. As a newly developed subject, metabolomics can detect accurately and quant...

see more →

News  13 results

The March of Immunotherapy Continues at ESMO 2020
https://www.medscape.com/viewarticle/937318

Sep 14th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

The March of Immunotherapy Continues at ESMO 2020
https://www.staging.medscape.com/viewarticle/937318

Sep 14th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

An 8-Year-Old Boy With Autism, Lupus, Fever, and Chest Pain
https://reference.medscape.com/viewarticle/932635_4

Jun 23rd, 2020 - CMMRD is a biallelic germline mutation in the mismatch repair (MMR) genes that results in dysfunction of the DNA mismatch repair system. This leads to an inability to correct replication errors in dividing cells, causing a rapid accumulation of mu...

Emerging Platform Technology for Cancer: Nuclear Imaging
https://www.medscape.com/viewarticle/901270

Sep 6th, 2018 - Hello. I'm David Kerr, professor of cancer medicine from University of Oxford. I'm never one not to be self-promoting. That's a gentle joke. Most of you are used to me talking about gastrointestinal tumors, but I wanted to stray into other areas b...

Open Clinical Trials for Patients With Renal Cell Carcinoma
https://www.mdedge.com/fedprac/article/143947/hematology/open-clinical-trials-patients-renal-cell-carcinoma-full/page/0/1

Aug 8th, 2018 - Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery This randomized phase II trial studies how well tivantinib with or without erlotinib hydroc.

see more →